BACKGROUND Bax-interacting factor-1 (Bif-1) is well-documented in the regulation of cancers and neurodegenerative disorders. However, its role in vascular diseases remains largely unexplored. Here, we demonstrate a critical role for Bif-1 in the pathogenesis of vascular remodeling following injury. METHODS AND RESULTS Using both knockdown and overexpression strategies, we found that Bif-1 knockdown inhibited the proliferation, migration, and phenotypic switch of vascular smooth muscle cells (VSMCs) and attenuated vascular remodeling upon injury. Conversely, Bif-1 overexpression exacerbated these pathological processes. Mechanistically, we showed that β-catenin signaling was regulated by Bif-1. Importantly, the interaction between Bif-1 and Axin2 was promoted upon angiotensin II (Ang II) stimulation, which is correlated with the activation of β-catenin signaling. CONCLUSIONS Together, our findings suggest that Bif-1 is a novel vascular injury-response molecule that promotes VSMC proliferation, migration, and phenotypic switch. Thus, the inhibition of Bif-1-mediated activation of β-catenin signaling represents a promising therapeutic strategy for preventing VSMC accumulation and vascular obstructive diseases following injury.
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
The Journal of pharmacy and pharmacology
- Publication date
2025-11-12
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-37 of 37 references · Page 1 of 1
CITED BY
- No citing papers are available for this paper.
Showing 0-0 of 0 citing papers · Page 1 of 1